New research suggests people who are scheduled for certain medical procedures should stop taking popular weight loss drugs in the days or weeks prior to avoid complications. New research from ...
GLP-1 drugs like Ozempic and Wegovy can help most people lose weight, but they don’t work for everyone. Here are 5 common ...
Drugmakers are preparing to launch an estimated 13 new weight-loss treatments in the U.S. over the next five years, according ...
The new obesity drugs might be an exception to a chronic, deadly problem: the failure to stick with medication. Credit...Photo Illustration by Matt Chase Supported by By Gina Kolata Most people ...
Some Medicare members could get help paying for the popular new weight-loss drug Wegovy—as long as they have a history of heart disease and are using it to prevent recurring heart attacks and ...
NEW YORK, March 22 (Reuters Breakingviews) - Novo Nordisk (NOVOb.CO) , opens new tab have inched closer to justifying their enormous valuations. The U.S. government said Thursday it would pay for ...
Produced by ElevenLabs and News Over Audio (NOA) using AI narration. “In my lifetime, I never dreamed that we would be talking about medicines that are providing hope for people like me ...
New treatments for diabetes and obesity, like Ozempic, attract significant attention for both their effects on clinical outcomes and health care spending. In this piece, I use newly released data ...
Research has also shown that obesity-related health issues account for more than 20 percent of all healthcare costs.
The Centers for Medicare and Medicaid Services (CMS) issued guidance allowing for the coverage of anti-obesity medications, but only in cases they are indicated for treating conditions other than ...
Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Twinamatsiko and Ranganathan are experts in health law and ...